share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga Real-time News ·  Aug 8, 2022 20:15

 

Gainers

  • Cerevel Therapeutics Hldg (NASDAQ:CERE) stock increased by 18.0% to $39.49 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 billion.
  • Eargo (NASDAQ:EAR) stock increased by 17.88% to $1.45. The market value of their outstanding shares is at $57.0 million. The company's, Q2 earnings came out today.
  • Signify Health (NYSE:SGFY) stock rose 15.7% to $22.99. The market value of their outstanding shares is at $4.0 billion. As per the news, the Q2 earnings report came out 3 days ago.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares moved upwards by 15.31% to $6.1. The market value of their outstanding shares is at $4.8 million.
  • Zai Lab (NASDAQ:ZLAB) stock increased by 14.62% to $51.89. The company's market cap stands at $5.0 billion.
  • CinCor Pharma (NASDAQ:CINC) stock moved upwards by 13.47% to $26.61. The market value of their outstanding shares is at $1.0 billion.

Losers

  • Reata Pharmaceuticals (NASDAQ:RETA) shares fell 18.8% to $28.99 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q2 earnings report came out today.
  • Marker Therapeutics (NASDAQ:MRKR) shares declined by 14.17% to $0.46. The company's market cap stands at $38.7 million.
  • Scholar Rock Holding (NASDAQ:SRRK) shares decreased by 12.0% to $7.48. The company's market cap stands at $386.1 million.
  • Cognition Therapeutics (NASDAQ:CGTX) stock declined by 11.83% to $2.76. The company's market cap stands at $62.3 million.
  • Aethlon Medical (NASDAQ:AEMD) shares fell 10.18% to $1.5. The market value of their outstanding shares is at $24.9 million.
  • Athenex (NASDAQ:ATNX) shares fell 9.69% to $0.86. The market value of their outstanding shares is at $104.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment